Clinical Roundup Ten-year follow-up data shows Opdivo + Yervoy improves OS in advanced melanoma September 20, 2024Vol.50 No.35
Clinical Roundup Data from phase I/II study shows Rina-S improves ORR for treatment of ovarian cancer September 20, 2024Vol.50 No.35
Clinical Roundup Accelerated partial-breast irradiation is not statistically equivalent to whole-breast irradiation in local tumor control, NRG oncology trial shows September 20, 2024Vol.50 No.35
Clinical Roundup Novel tumor models provide insights into deadly sarcomas September 20, 2024Vol.50 No.35
Clinical Roundup Combination therapy shows reduced agitated delirium in patients with advanced cancers September 20, 2024Vol.50 No.35
Clinical Roundup Incyte’s CDK2 inhibitor shows evidence of clinical activity in treating advanced solid tumors, notably ovarian cancer September 20, 2024Vol.50 No.35
Clinical Roundup NIH study links neighborhood environment to prostate cancer risk in men with West African genetic ancestry September 20, 2024Vol.50 No.35
Clinical Roundup Wistar Institute researchers identify the role of a Parkinson’s disease-related protein in cancer and T-cell activation September 20, 2024Vol.50 No.35
Clinical Roundup Friends of Cancer Research announces publication focused on enhancing clinical trials with pragmatic trial elements September 13, 2024Vol.50 No.34
